CD40 drives tumor growth in non-small cell lung cancer via non-canonical immune-independent mechanisms. [PDF]
Liu Y +11 more
europepmc +1 more source
Integration of single cell and bulk transcriptomic analyses identifies FAM189A2 as a key prognostic gene in lung cancer. [PDF]
Guo P, Xiang M, Chen J, Zhang H.
europepmc +1 more source
Impact of MEK inhibition on T-cell infiltration and function after radiotherapy in KRAS-mutant lung cancer. [PDF]
Zheng Y +8 more
europepmc +1 more source
WEE1 inhibitor exerts synergistic effect with KRAS G12C inhibitor via MYBL2-RRM2 axis in KRASG12C-mutant lung cancer. [PDF]
Zhou C +8 more
europepmc +1 more source
miR-3613-5p promotes lung cancer progression by targeting and regulating XPO6. [PDF]
Wang X, Li H, Wu X.
europepmc +1 more source
Inhibition of primary ciliogenesis enhances efficacy of EGFR‑TKIs against non‑small cell lung cancer cells. [PDF]
Jin L +6 more
europepmc +1 more source
Green Growth Nexus: Analysing Environmental Performance and GDP Trends in OECD Economies
Keerthana K +4 more
doaj +1 more source
Ribonucleotide reductase M1 regulates the cell cycle via minichromosome maintenance proteins. [PDF]
Malysa A +7 more
europepmc +1 more source
1-(4-Bromo-phen-yl)-4,5-diphenyl-2-(1<i>H</i>-pyrrol-2-yl)-1<i>H</i>-imidazole. [PDF]
Nagaraj S, Loganathan N.
europepmc +1 more source
1-(4-Methyl-benzene-sulfon-yl)-1-phenyl-1<i>H</i>,2<i>H</i>-cyclo-buta[<i>c</i>]quinoline. [PDF]
Schollmeyer D +2 more
europepmc +1 more source

